Insider Sale: Director at $EXAS Sells 3,207 Shares

Director Katherine S Zanotti sold 3,207 shares of $EXAS on 06-13-2025 for approximately $170,612, representing 4.2% of their holdings, leaving them with 72,759 shares. Over the last quarter, institutional investors showed mixed sentiment, with FMR LLC increasing its position by 33.6% while JPMORGAN CHASE & CO decreased theirs by 85.6%; analysts currently have a consensus "Buy" rating with a median price target of $65.

Analysis

A recent SEC filing for $EXAS revealed that director Katherine S Zanotti sold 3,207 shares on June 13, 2025, for an estimated $170,612, a transaction constituting approximately 4.2% of her holdings in that class of stock, leaving her with 72,759 shares. This sale is notable as it is the only open market insider transaction recorded for $EXAS in the past six months. Institutional activity in Q1 2025 presents a divergent picture: while 240 institutional investors added $EXAS shares, a larger number, 373, reduced their positions. Significant movements include FMR LLC increasing its stake by 6,970,041 shares (+33.6%) and UBS AM adding 1,707,287 shares (+120.1%). Conversely, JPMORGAN CHASE & CO substantially decreased its holdings by 2,989,522 shares (-85.6%), and ARTISAN PARTNERS LIMITED PARTNERSHIP fully liquidated its position of 2,009,503 shares. Despite this mixed institutional sentiment, Wall Street analyst coverage remains positive, with two firms issuing buy-equivalent ratings in recent months (Guggenheim "Buy" on 03/28/2025; Evercore ISI "Outperform" on 01/02/2025) and no sell ratings reported. The median price target from these two analysts stands at $65.0, with individual targets of $60.0 from Guggenheim and $70.0 from Evercore ISI.

Key Decisions for Investors

• Investors should closely monitor the next quarterly institutional holding disclosures to ascertain whether the observed divergence in Q1 2025, with more firms decreasing than increasing positions despite some large new stakes, develops into a clearer trend.
• The director's sale, while the sole insider transaction in six months, represented a relatively small portion of her total holdings and should be weighed alongside her remaining substantial investment rather than being viewed as an isolated strong bearish signal.
• While current analyst ratings are favorable with a median price target of $65.0, this optimism should be balanced against the net reduction in the number of institutional holders and significant divestitures by prominent funds like JPMORGAN CHASE & CO and ARTISAN PARTNERS LIMITED PARTNERSHIP.